EUCOPE: EU Pharma Reform Positive, But Industry Needs Clearer Definitions
Executive Summary
High unmet needs is among the terms and definitions in the EU’s regulatory reform package that are “very subjective” and require more clarity to improve predictability for the pharmaceutical industry, EUCOPE’s secretary general, Alexander Natz, tells the Pink Sheet.